Premium
A phase I trial of a rhenium 186‐labeled monoclonal antibody administered intraperitoneally in ovarian carcinoma: Toxicity and clinical response
Author(s) -
Jacobs A.J.,
Fer M.,
Su F.M.,
Breitz H.,
Thompson J.,
Goodgold H.,
Cain J.,
Heaps J.,
Weiden P.
Publication year - 1994
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(94)90291-7
Subject(s) - medicine , toxicity , ovarian carcinoma , radioimmunotherapy , chemotherapy , gastroenterology , immunoconjugate , monoclonal antibody , ovarian cancer , rash , carcinoma , ovary , leukopenia , urology , oncology , antibody , immunology , cancer